Oscar Health (OSCR) Expected to Announce Earnings on Wednesday

Oscar Health (NYSE:OSCR) is expected to be releasing its earnings data before the market opens on Wednesday, February 5th. Analysts expect Oscar Health to post earnings of ($0.55) per share and revenue of $2.47 billion for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. During the same period last year, the business posted ($0.29) earnings per share. The company’s quarterly revenue was up 68.3% on a year-over-year basis. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Trading Up 0.7 %

Shares of Oscar Health stock opened at $16.72 on Tuesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a 50-day moving average of $15.22 and a two-hundred day moving average of $16.85. Oscar Health has a 12-month low of $12.84 and a 12-month high of $23.79. The stock has a market cap of $4.13 billion, a PE ratio of -278.55, a price-to-earnings-growth ratio of 0.67 and a beta of 1.73.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on OSCR shares. UBS Group started coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective for the company. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, Jefferies Financial Group started coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $21.56.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of Oscar Health stock in a transaction that occurred on Tuesday, November 12th. The shares were acquired at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the acquisition, the director now owns 5,452,081 shares of the company’s stock, valued at $74,584,468.08. The trade was a 8.36 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, Vice Chairman Joshua Kushner bought 276,040 shares of Oscar Health stock in a transaction that occurred on Monday, November 11th. The shares were acquired at an average price of $13.58 per share, for a total transaction of $3,748,623.20. Following the acquisition, the insider now directly owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. This represents a 5.80 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by company insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.